Pemetrexed

Spezifikationen

137281-23-3CAS-Nummer

680-625-9EG-Nummer

(2S)-2-[[4-[2-(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acidIUPAC-Name

C20H21N5O6Chemische Formel

427.4 g/molMolekulargewicht

Pemetrexed; 137281-23-3; LY231514; NSC-698037; 04Q9AIZ7NO; PEMFEXY; CHEBI:63616; LY-231514; DTXSID2048329; N-(4-(2-(2-Amino-3,4-dihydro-4-oxo-7H-pyrrolo(2,3-d)pyrimdin-5-yl)ethyl)benzoyl)glutamic acid; N-{4-[2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl}-L-glutamic acid; Pemetrexed Sodium; L-Glutamic acid, N-(4-(2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo(2,3-d)pyrimidin-5-yl)ethyl)benzoyl)-; pemetrexedum; N-(4-(2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo(2,3-d)pyrimidin-5-yl)ethyl)benzoyl)-L-glutamic acid; AXTLE; Multitargeted Antifolate; RefChem:6105; PEMETREXED FOR INJECTION; DTXCID7028304; (2R)-2-((4-(2-(2-amino-4-oxo-1,7-dihydropyrrolo(4,5-e)pyrimidin-5-yl)ethyl)benzoyl)amino)pentanedioic acid; 231514, LY; LY-231,514; 231,514, LY; L-Glutamic Acid, N-(4-(2-(2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo(2,3-d)pyrimidin-5-yl)ethyl)benzoyl); Alimta; (S)-2-(4-(2-(2-Amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzamido)pentanedioic acid; N-[4-[2-(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid; L-Glutamic acid, N-[4-[2-(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-; N-[4-[2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid; Pemetrexed (INN); PEMETREXED [INN]; Alimta (TN); (2S)-2-[[4-[2-(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid; 2-{4-[2-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYLAMINO}-PENTANEDIOIC ACID; N-[4-[2-(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamicacid; (2S)-2-{[4-(2-{2-amino-4-oxo-3H,4H,7H-pyrrolo[2,3-d]pyrimidin-5-yl}ethyl)phenyl]formamido}pentanedioic acid; LYA; Pemetrexed [INN:BAN]; UNII-04Q9AIZ7NO; MFCD19105065; s5971; HSDB 7316; 1juj; Pemetrexed Hydrate; Pemetrexed (TN); (S)-2-[4-[2-(2-Amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzamido]pentanedioic Acid; L-GLUTAMIC ACID, N-(4-(2-(2-AMINO-4,7-DIHYDRO-4-OXO-3H-PYRROLO(2,3-D)PYRIMIDIN-5-YL)ETHYL)BENZOYL)-; N-(4-(2-(2-AMINO-4,7-DIHYDRO-4-OXO-1H-PYRROLO(2,3-D)PYRIMIDIN-5-YL)ETHYL)BENZOYL)-L-GLUTAMIC ACID; N-(4-[2-(2-amino-4,7-Dihydro-4-Oxo-1H-Pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl)-L-Glutamic Acid; Pemfexy (TN); Pemetrexed (Standard); PEMETREXED [MI]; Alimta (TN) (Lilly); PEMETREXED [HSDB]; PEMETREXED [VANDF]; SCHEMBL7968; PEMETREXED [WHO-DD]; US9422297, Pemetrexed; (2S)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid; PEMETREXED [EMA EPAR]; SCHEMBL209720; CHEMBL225072; orb1310854; orb3141246; Pemetrexed - Bio-X trade mark; SCHEMBL7848273; SCHEMBL7848278; PEMETREXED [ORANGE BOOK]; Premetrexed [Common mis-spelling]; WBXPDJSOTKVWSJ-ZDUSSCGKSA-N; BDBM50027656; EBC-24033; HY-10820R; AKOS015896253; AKOS016842348; AC-1701; CS-1297; DB00642; FP37935; LY-2315; NCGC00166414-11; NCGC00166414-22; NCGC00167517-01; NCGC00242485-01; AS-30680; BP164240; HY-10820; N-[4-[2(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid; SY105930; DB-024764; P2288; D07472; AB01273937-01; EN300-7396246; Q415220; L-Glutamic acid,3-d]pyrimidin-5-yl]ethyl]benzoyl]-; BRD-K32842773-304-03-9; BRD-K32842773-304-04-7; BRD-K32842773-434-01-8; 1006872-74-7; N-({4-[2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]phenyl}carbonyl)-L-glutamic acid; N-(P-(2-(2-AMINO-4,7-DIHYDRO-4-OXO-1H-PYRROLO(2,3-D)PYRIMIDIN-5-YL)ETHYL)BENZOYL)-L-GLUTAMATE; N-[4-[2(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo [2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid; N-[4-[2-(2-amino-3,4-dihydro-4-oxo-7h-pyrrolo[2,3-d]pyrimi-din-5-yl)ethyl]benzoyl]l-glutamic acid; N-[4-[2-[2-Amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl]ethyl]benzoyl]glutamic acid; Pémétrexed monohydratéSynonyme